Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Pfizer Combats Counterfeited Viagra in Hong Kong

Through serialization technology, pharmaceutical company Pfizer was able to target the distribution of counterfeit Viagra in Hong Kong.

Counterfeit drugs have been a major hurdle for pharmaceutical companies worldwide—approximately 73 billion euros of counterfeit medicine are distributed annually, according to the World Health Organization.  

 

Pfizer, a corporation that develops and produces medicine and vaccines for numerous medical disciplines, found that sales of their blockbuster drug Viagra were being undermined in Asian markets by major counterfeiting operations. In Hong Kong alone, approximately 40% of Viagra sales were found to be counterfeit.

 

To expose the fakes and increase the sales of the authentic drug, Pfizer turned to Kezzler’s serialization technology, which is designed to protect brands, track distribution, and strengthen consumer loyalty in the pharmaceutical industry using Kezzlercodes. Pfizer currently uses Norway-based Kezzler’s serialization technology to protect eight of its biggest brands.

 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report